Mallinckrodt Falls 7% On Adverse FDA News

By: via Benzinga
Mallinckrodt plc (NYSE: MNK) released a press release Thursday after it was informed by the U.S. Food and Drug Administration that ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.